Conference Paper
BibTex RIS Cite

Dirençli ventriküler fibrilasyon ile karakterize postpartum kardiyomyopati

Year 2011, Volume: 28 Issue: 4, 182 - 185, 27.01.2012

Muhittin Çalım Cihan Bolat Hülya Tür Tülin Akarsu Ayazoğlu

https://doi.org/10.5835/jecm.omu.28.04.011

Abstract

Postpartum kardiyomyopati sık görülmeyen, gebeliğin son ayı ile doğumdan sonraki ilk 5 ay içerisinde gözlenen dilate kardiyomyopati olup nedeni bilinmemektedir. Etyolojide hormonal bozukluk, koroner spazm, viral, otoimmün ve idiyopatik miyokardit, hipertansiyon, apoptosis, genetik, inflamatuar sitokinlerin aktivasyonu hipotezleri sayılmaktadır. Gebelik kardiomyopatisinde yüksek mortalite ile ilişkilidir( aralık %20-50 arasında). Biz bu vaka takdiminde; nefes darlığı ve çarpıntı şikayetleri ile yoğun bakıma yatırılan postpartum dilate kardiyomyopati tanısı konan 25 yaşında olgunun dirençli VF atakları, transvenöz geçici pace-maker, intra aortik balon pompa desteği ve başarılı ortotropik kalp transplantasyonunu anlattık.

Keywords

Postpartum cardiomyopathy diagnosis treatment

References

  • Abboud, J., Murad, Y., Chen-Scarabelli, C., Saravolatz, L., Scarabelli, T.M., 2007. Peripartum cardiomypathy: a comprehensive review. Int. J. Cardiol. 118, 295-303
  • Albanesi Fo, F.M., Silva, T.T., 1999. O comportamento das gestações subseqüentes na cardiomiopatia periparto. Arq. Bras. Cardiol. 73, 47-52.
  • Bhakta, P., Biswas, B.K., Banerjee, B., 2007. Peripartum cardiomyopathy: review of the literature. Yonsei Med. J. 48, 731-747.
  • Bosch, T., 2005. Therapeutic apheresis state of the art in the year. Ther. Apher. Dial. 9, 459-468.
  • Davidson, N.M., Parry, E.H., 1979. The etiology of peripartum cardiac failure. Ann. Heart J. 97, 535-536.
  • Demakis, J.G., Rahimtoola, S.H, Sutton, G.C., 1971. Natural course of peripartum cardiomyopathy. Circulation. 44, 1053-1061.
  • Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J.J., Ponikowski, P., 2008. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. 10, 933-989.
  • Elkayam, U., Akhter, M.W., Singh, H.S., 2005. Pregnancy-Associated Cardiomyopathy: Clinical characteristics and a comparison between early and late presentation. Circulation. 111, 2050-2055.
  • Elliott, P., Andersson, B., Arbustini, E., 2008. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiol- ogy Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 29, 270-276.
  • Fekler, G.M., Jaeger, C.J., Klodas, M., 2000. Myocarditis and longterm survival in peripartum cardiomyopathy. Ann. Heart J. 140, 785-791.
  • Felix, S.B., Staudt, A., 2006. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects. Int. J. Cardiol. 112, 30-33.
  • Fennira, S., Demiraj, A., Khouaja, A., Boujnah, M.R., 2006. Peripartum cardiyomyopathy. Ann. Cardiol. Angeiol. 55, 271-275.
  • Jessup, M., Brozena, S., 2003. Heart failure. N. Engl. J. Med. 348, 2007-2018.
  • Kowara, M.L., Dudziak, M., Suchorzewska, J., 2001. Two cases of postpartum cardiomyopathy initially misdiagnosed for pulmonary embolism. Can. J. Anesth. 48, 773-774.
  • Kuhl, U., Pauschinger, M., Schwimmbeck, P.L., 2003. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 107, 2793-2798.
  • Li, W.M., Liu, W., Gao, C., Zhou, B.G., 2006. Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats. Immunol. Cell Biol. 84, 274-280.
  • Liu, Z., Yuan, J., Yanagawa, B., Qiu, D., McManus, B.M., Yang, D., 2005. Coxsackie virus induced myocarditis: new trends in treatment. Expert. Rev. Anti Infect Ther. 3, 641-650.
  • Navascues, A.R., Marin, R., Testa, A., Paneda, F., Grande, A.J., 2001 Preeclampsia and peripartum cardiomyopathy. Nefrologia. 21, 84-87.
  • Palanzo, D.A., Baer, L.D., El-Banayosy, A., Stephenson, E., Mulvey, S., McCoach, R.M., Wise, R.K., Woitas, K.R., Pae, W.E., 2009. Successful treatment of peripartum cardiomyopathy with extracorporeal membrane oxygenation. Perfusion. 24, 75-79.
  • Pearson, G.D., Veille, J.C., Rahimtoola, S., 2000. Peripartum cardiomyopathy National Heart, Lung and Blood Institute and Office of Rare Dis- eases (National Institutes of Health) workshop recommendations and review. J.A.M.A. 283, 1183-1188.
  • Sahraoui, W., Hajji, S., Haouas, N., El Mejri, L., Slama, A., Ernez, S., 2007 . Peripartum cardiomyopathy. Tunis Med. 85, 473-478.
  • Sliwa, K., Blauwet, L., Tibazarwa, K., Libhaber, E., Smedema, J.P., Becker, A., McMurray, J., Yamac, H., Labidi, S., Struman, I., Hilfiker- Kleiner, D., 2010. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 121, 1465-1473.
  • Smith, I.J., Gillham, M.J., 2009. Fulminant peripartum cardiomyopathy rescue with extracorporeal membranous oxygenation. Int. J. Obstet. Anesth. 18, 186-188.
  • Sutton, M.S.J., Cole, P., Plappert, M., 1991. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Ann. Heart J. 121, 1776-1778.
  • Tidswell, M. 2004. Peripartum cardiomyopathy. Crit. Care. Clin. 20, 777-778.
  • Yang, H.S., Hong, Y.S., Rim, S.J., Yu, S.H., 2007. Extracorporeal membrane oxygenation in a patient with peripartum cardiomyopathy. Ann. Thorac. Surg. 84, 262-264.
  • Yu, C.M., Abraham, W.T., Bax, J., Chung, E., Fedewa, M., Ghio, S., 2005. PROSPECT Investigators. Predictors of response to cardiac resyn- chronization therapy (PROSPECT)-study design. Ann. Heart J. 149, 600-605.
  • Yuan, H.T., Liao, Y.H., Wang, Z., 2003. Prevention of myosin-induced autoimmune myocarditis in mice by anti-L3T4 monoclonal antibody. Can. J. Physiol. Pharmacol. 81, 84-88.
  • Yuan, Z., Kishimoto, C., Shioji, K., 2003. Beneficial effects of low-dose benidipine in acute autoimmune myocarditis: suppressive effects on inflammatory cytokines and inducible nitric oxide synthase. Circulation J. 67, 545-550.
  • Zimmerman, H., Bose, R., Smith, R., Copeland, J.G., 2010. Treatment of peripartum cardiomyopathy with mechanical assist devices and cardiac transplantation. Ann. Thorac. Surg. 89, 1211-1217.

Year 2011, Volume: 28 Issue: 4, 182 - 185, 27.01.2012

Muhittin Çalım Cihan Bolat Hülya Tür Tülin Akarsu Ayazoğlu

https://doi.org/10.5835/jecm.omu.28.04.011

Abstract

References

  • Abboud, J., Murad, Y., Chen-Scarabelli, C., Saravolatz, L., Scarabelli, T.M., 2007. Peripartum cardiomypathy: a comprehensive review. Int. J. Cardiol. 118, 295-303
  • Albanesi Fo, F.M., Silva, T.T., 1999. O comportamento das gestações subseqüentes na cardiomiopatia periparto. Arq. Bras. Cardiol. 73, 47-52.
  • Bhakta, P., Biswas, B.K., Banerjee, B., 2007. Peripartum cardiomyopathy: review of the literature. Yonsei Med. J. 48, 731-747.
  • Bosch, T., 2005. Therapeutic apheresis state of the art in the year. Ther. Apher. Dial. 9, 459-468.
  • Davidson, N.M., Parry, E.H., 1979. The etiology of peripartum cardiac failure. Ann. Heart J. 97, 535-536.
  • Demakis, J.G., Rahimtoola, S.H, Sutton, G.C., 1971. Natural course of peripartum cardiomyopathy. Circulation. 44, 1053-1061.
  • Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J.J., Ponikowski, P., 2008. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. 10, 933-989.
  • Elkayam, U., Akhter, M.W., Singh, H.S., 2005. Pregnancy-Associated Cardiomyopathy: Clinical characteristics and a comparison between early and late presentation. Circulation. 111, 2050-2055.
  • Elliott, P., Andersson, B., Arbustini, E., 2008. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiol- ogy Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 29, 270-276.
  • Fekler, G.M., Jaeger, C.J., Klodas, M., 2000. Myocarditis and longterm survival in peripartum cardiomyopathy. Ann. Heart J. 140, 785-791.
  • Felix, S.B., Staudt, A., 2006. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects. Int. J. Cardiol. 112, 30-33.
  • Fennira, S., Demiraj, A., Khouaja, A., Boujnah, M.R., 2006. Peripartum cardiyomyopathy. Ann. Cardiol. Angeiol. 55, 271-275.
  • Jessup, M., Brozena, S., 2003. Heart failure. N. Engl. J. Med. 348, 2007-2018.
  • Kowara, M.L., Dudziak, M., Suchorzewska, J., 2001. Two cases of postpartum cardiomyopathy initially misdiagnosed for pulmonary embolism. Can. J. Anesth. 48, 773-774.
  • Kuhl, U., Pauschinger, M., Schwimmbeck, P.L., 2003. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 107, 2793-2798.
  • Li, W.M., Liu, W., Gao, C., Zhou, B.G., 2006. Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats. Immunol. Cell Biol. 84, 274-280.
  • Liu, Z., Yuan, J., Yanagawa, B., Qiu, D., McManus, B.M., Yang, D., 2005. Coxsackie virus induced myocarditis: new trends in treatment. Expert. Rev. Anti Infect Ther. 3, 641-650.
  • Navascues, A.R., Marin, R., Testa, A., Paneda, F., Grande, A.J., 2001 Preeclampsia and peripartum cardiomyopathy. Nefrologia. 21, 84-87.
  • Palanzo, D.A., Baer, L.D., El-Banayosy, A., Stephenson, E., Mulvey, S., McCoach, R.M., Wise, R.K., Woitas, K.R., Pae, W.E., 2009. Successful treatment of peripartum cardiomyopathy with extracorporeal membrane oxygenation. Perfusion. 24, 75-79.
  • Pearson, G.D., Veille, J.C., Rahimtoola, S., 2000. Peripartum cardiomyopathy National Heart, Lung and Blood Institute and Office of Rare Dis- eases (National Institutes of Health) workshop recommendations and review. J.A.M.A. 283, 1183-1188.
  • Sahraoui, W., Hajji, S., Haouas, N., El Mejri, L., Slama, A., Ernez, S., 2007 . Peripartum cardiomyopathy. Tunis Med. 85, 473-478.
  • Sliwa, K., Blauwet, L., Tibazarwa, K., Libhaber, E., Smedema, J.P., Becker, A., McMurray, J., Yamac, H., Labidi, S., Struman, I., Hilfiker- Kleiner, D., 2010. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 121, 1465-1473.
  • Smith, I.J., Gillham, M.J., 2009. Fulminant peripartum cardiomyopathy rescue with extracorporeal membranous oxygenation. Int. J. Obstet. Anesth. 18, 186-188.
  • Sutton, M.S.J., Cole, P., Plappert, M., 1991. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Ann. Heart J. 121, 1776-1778.
  • Tidswell, M. 2004. Peripartum cardiomyopathy. Crit. Care. Clin. 20, 777-778.
  • Yang, H.S., Hong, Y.S., Rim, S.J., Yu, S.H., 2007. Extracorporeal membrane oxygenation in a patient with peripartum cardiomyopathy. Ann. Thorac. Surg. 84, 262-264.
  • Yu, C.M., Abraham, W.T., Bax, J., Chung, E., Fedewa, M., Ghio, S., 2005. PROSPECT Investigators. Predictors of response to cardiac resyn- chronization therapy (PROSPECT)-study design. Ann. Heart J. 149, 600-605.
  • Yuan, H.T., Liao, Y.H., Wang, Z., 2003. Prevention of myosin-induced autoimmune myocarditis in mice by anti-L3T4 monoclonal antibody. Can. J. Physiol. Pharmacol. 81, 84-88.
  • Yuan, Z., Kishimoto, C., Shioji, K., 2003. Beneficial effects of low-dose benidipine in acute autoimmune myocarditis: suppressive effects on inflammatory cytokines and inducible nitric oxide synthase. Circulation J. 67, 545-550.
  • Zimmerman, H., Bose, R., Smith, R., Copeland, J.G., 2010. Treatment of peripartum cardiomyopathy with mechanical assist devices and cardiac transplantation. Ann. Thorac. Surg. 89, 1211-1217.
There are 30 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Surgery Medical Sciences
Authors

Muhittin Çalım This is me

Cihan Bolat

Hülya Tür This is me

Tülin Akarsu Ayazoğlu

Publication Date January 27, 2012
Submission Date June 13, 2011
Published in Issue Year 2011 Volume: 28 Issue: 4

Cite

APA Çalım, M., Bolat, C., Tür, H., Akarsu Ayazoğlu, T. (2012). Dirençli ventriküler fibrilasyon ile karakterize postpartum kardiyomyopati. Journal of Experimental and Clinical Medicine, 28(4), 182-185. https://doi.org/10.5835/jecm.omu.28.04.011
AMA Çalım M, Bolat C, Tür H, Akarsu Ayazoğlu T. Dirençli ventriküler fibrilasyon ile karakterize postpartum kardiyomyopati. J. Exp. Clin. Med. March 2012;28(4):182-185. doi:10.5835/jecm.omu.28.04.011
Chicago Çalım, Muhittin, Cihan Bolat, Hülya Tür, and Tülin Akarsu Ayazoğlu. “Dirençli ventriküler Fibrilasyon Ile Karakterize Postpartum Kardiyomyopati”. Journal of Experimental and Clinical Medicine 28, no. 4 (March 2012): 182-85. https://doi.org/10.5835/jecm.omu.28.04.011.
EndNote Çalım M, Bolat C, Tür H, Akarsu Ayazoğlu T (March 1, 2012) Dirençli ventriküler fibrilasyon ile karakterize postpartum kardiyomyopati. Journal of Experimental and Clinical Medicine 28 4 182–185.
IEEE M. Çalım, C. Bolat, H. Tür, and T. Akarsu Ayazoğlu, “Dirençli ventriküler fibrilasyon ile karakterize postpartum kardiyomyopati”, J. Exp. Clin. Med., vol. 28, no. 4, pp. 182–185, 2012, doi: 10.5835/jecm.omu.28.04.011.
ISNAD Çalım, Muhittin et al. “Dirençli ventriküler Fibrilasyon Ile Karakterize Postpartum Kardiyomyopati”. Journal of Experimental and Clinical Medicine 28/4 (March 2012), 182-185. https://doi.org/10.5835/jecm.omu.28.04.011.
JAMA Çalım M, Bolat C, Tür H, Akarsu Ayazoğlu T. Dirençli ventriküler fibrilasyon ile karakterize postpartum kardiyomyopati. J. Exp. Clin. Med. 2012;28:182–185.
MLA Çalım, Muhittin et al. “Dirençli ventriküler Fibrilasyon Ile Karakterize Postpartum Kardiyomyopati”. Journal of Experimental and Clinical Medicine, vol. 28, no. 4, 2012, pp. 182-5, doi:10.5835/jecm.omu.28.04.011.
Vancouver Çalım M, Bolat C, Tür H, Akarsu Ayazoğlu T. Dirençli ventriküler fibrilasyon ile karakterize postpartum kardiyomyopati. J. Exp. Clin. Med. 2012;28(4):182-5.
 Download Cover Image

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.